tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market
Holding TRVI?
Track your performance easily

Trevi Therapeutics (TRVI) Stock Investors

304 Followers
Based on 757,682 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold TRVI
On average, investors allocate 0.00% of their portfolios to TRVI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,682 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding TRVI

4.5%
Last 7
Days
4.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding TRVI, out of 757,682 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

TRVI Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,481 investors who made their portfolios public
The table shows changes in TRVI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

TRVI Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.60%
-1.71%
-0.10%
34.51B
Consumer Cyclical
Plug Power
5.10%
-1.06%
-2.74%
1.71B
Industrials
Devon Energy
5.02%
-0.58%
-1.06%
25.54B
Energy
Marathon Digital Holdings
5.31%
-1.40%
-1.89%
4.58B
Financial
Coherus Biosciences
2.45%
+0.79%
-0.38%
117.51M
Healthcare
Riot Platforms
4.73%
-0.98%
-2.05%
2.18B
Financial
Blink Charging Co
5.32%
-1.78%
-3.62%
176.00M
Industrials
XPeng, Inc. ADR
5.50%
-1.49%
-3.27%
9.23B
Consumer Cyclical
Li Auto
5.58%
-1.36%
-3.28%
21.78B
Consumer Cyclical
Nio
9.89%
-1.09%
-1.33%
11.18B
Consumer Cyclical
Based on the activity of 757,682 active portfolios
Open your Smart Portfolio

TRVI Investor Analysis

TRVI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of TRVI holders
are under 35
Average Segment Performance
Average P/E Ratio21.02
Beta8.34
Dividend Yield3.05%
TRVI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.3%
of TRVI holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.08
Beta14.24
Dividend Yield3.52%
TRVI investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
28.6%
of TRVI holders
are over 55
Average Segment Performance
Average P/E Ratio20.89
Beta7.01
Dividend Yield3.28%
Overview of age group and performance of TRVI stock investors
See who invests in TRVI according to age group and performance.

FAQ

How many retail Investors hold TRVI?
<0.1% of TipRanks' retail investors hold TRVI in their portfolios.
    What is TRVI Investor Sentiment?
    TRVI’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of TRVI in the last 7 days?
      ▼ 4.5% of TipRanks' retail investors changed their holding of TRVI in the last 7 days.
        What percentage of retail investors changed their holding of TRVI in the last 30 days?
        ▼ 4.9% of TipRanks' retail investors changed their holding of TRVI in the last 30 days.
          What is the average age of retail investors who hold TRVI?
          The average age of TRVI Holders is between 35–55.
            What other stocks have TRVI investors also bought?
            TRVI Investors also bought DKNG, PLUG, DVN, MARA, CHRS, RIOT, BLNK, XPEV, LI, NIO.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              CORTCorcept Therapeutics
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis